Clinical Trials on Benign Female Reproductive System Neoplasm in New Zealand
Total 9443 results
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
Onconova Therapeutics, Inc.RecruitingEndometrioid Endometrial CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAtypical Endometrial Hyperplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid AdenocarcinomaUnited States
-
Roswell Park Cancer InstituteRecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Metastatic Bladder Carcinoma | Locally Advanced Bladder Carcinoma | Unresectable Bladder CarcinomaUnited States
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC; Loxo Oncology, Inc.RecruitingUrinary Bladder Neoplasms | Neoplasm Metastasis | Ureteral NeoplasmsUnited States, Korea, Republic of, Spain, United Kingdom, Germany, Japan, France, China, Australia, Netherlands, Canada, Israel, Norway, Italy
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
PROCEPT BioRoboticsCompletedBenign Prostatic Hyperplasia (BPH)United States, Canada
-
AstraZenecaParexelApproved for marketing
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
Herbert Irving Comprehensive Cancer CenterCompletedCervical CancerUnited States
-
Far Eastern Memorial HospitalUnknownBreast Cancer, FemaleTaiwan
-
Compugen LtdBristol-Myers SquibbActive, not recruitingHead and Neck Cancer | Ovarian Cancer | Solid Tumor | Endometrial NeoplasmsUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedStage II Uterine Corpus Cancer | Endometrial Adenocarcinoma | Stage IA Uterine Corpus Cancer | Stage IB Uterine Corpus Cancer | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage IVA Uterine Corpus Cancer | Stage IVB Uterine Corpus CancerUnited States
-
Australia New Zealand Gynaecological Oncology GroupMerck Sharp & Dohme LLC; Eisai Inc.RecruitingUterine Carcinosarcoma | Ovarian CarcinosarcomaCanada, Australia, United Kingdom
-
National Cancer Institute (NCI)CompletedPeritoneal Neoplasms | Fallopian Tube Cancer | Epithelial Ovarian CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingMelanoma | Renal Cell Carcinoma | Non-Small Cell Lung CancerPoland, United States, Argentina, Chile, Japan, Australia, France, New Zealand, South Africa, Turkey
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
AstraZenecaMerck Sharp & Dohme LLCCompletedAdvanced Ovarian CancerUnited States
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia
-
University of OklahomaTesaro, Inc.RecruitingRecurrent Cervix Cancer | Progressive Cervix CancerUnited States
-
Gradalis, Inc.Active, not recruitingOvarian Neoplasms | Ovarian CancerUnited States
-
Alliance Foundation Trials, LLC.Eli Lilly and Company; Pfizer; Genentech, Inc.; Foundation MedicineRecruitingEndometrial CancerUnited States
-
Urovant Sciences GmbHRecruitingNeurogenic Detrusor OveractivityUnited States
-
Massive Bio, Inc.RecruitingMelanoma | Follicular Lymphoma | Carcinoma | Myelodysplastic Syndromes | Leukemia | Cancer | Breast Cancer | Myeloproliferative Disorders | Glioblastoma | Myelofibrosis | Ovarian Cancer | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Neuroendocrine Tumors | Non Small Cell Lung Cancer | COVID | Non Hodgkin Lymphoma | Cholang... and other conditionsUnited States
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
Memorial Sloan Kettering Cancer CenterColumbia University; Icahn School of Medicine at Mount Sinai; Weill Medical College...Active, not recruitingKidney Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Colon CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Washington University School of MedicineNational Cancer Institute (NCI); Aravive, Inc.Not yet recruitingRecurrent High Grade Uterine CancerUnited States
-
AstraZenecaCompletedMelanoma | Neoplasms | Renal Cell Carcinoma | Prostatic Neoplasms | Colorectal Neoplasms | Patients Who Have/Have Had Melanoma and Other TumorsUnited States, United Kingdom
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
Merck Sharp & Dohme LLCRecruitingSolid Tumor | Endometrial Cancer | Cutaneous Squamous Cell CarcinomaCanada, Australia, Taiwan, Italy, Malaysia, United States, Netherlands, Turkey, France, Germany
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingBladder CarcinomaUnited States
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
Tenet MedicinesTerminatedFocal Segmental Glomerulosclerosis | Minimal Change DiseaseUnited States
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
Washington University School of MedicineNational Cancer Institute (NCI)Not yet recruitingEndometrial Hyperplasia | Grade 1 Endometrial CancerUnited States
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
Dartmouth-Hitchcock Medical CenterTrustees of Dartmouth CollegeCompletedBreast Cancer FemaleUnited States
-
Splash Pharmaceuticals, Inc.UnknownOvarian Epithelial CancerUnited States
-
Arcus Biosciences, Inc.RecruitingClear Cell Renal Cell Carcinoma | Solid TumorsKorea, Republic of, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbActive, not recruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Australasian Gastro-Intestinal Trials GroupCompletedMetastatic Colorectal CancerAustralia, New Zealand
-
Laekna LimitedActive, not recruitingPlatinum-resistant Ovarian CancerUnited States, China
-
Sutro Biopharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Korea, Republic of, Israel, Singapore, Canada
-
Baylor College of MedicineMedical University of South Carolina; M.D. Anderson Cancer Center; The University... and other collaboratorsCompletedAnal High Grade Squamous Intraepithelial LesionUnited States
-
Eli Lilly and CompanyTerminatedBenign Prostatic HyperplasiaUnited States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
-
MedImmune LLCRecruitingAdvanced Renal Cell CarcinomaUnited States, Spain, France, Australia
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States